Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Sigmund who wrote (954)	1/6/1998 9:21:00 AM
From: Cisco	Read Replies (1) \| Respond to of 1894

Jeepers Sigmund: Where do you live? This post was at 3:04 in the moringing here. The companies that I believe would be hurt badly if approval is denied are NPTH, NSIX, CVSN, and possibly ACYT. Ironically, NSIX, CVSN, and ACYT could be hurt either way. Personnally, I believe CYTC and ACMI will be popping the champagne! ACMI doesn't have any pending PMAs that I know of. Are you telling me that NeoPath was crazy enough to go for a PMA approval without any substantial data? Perhaps they didn't understand that one must first go through the Lincoln Bedroom for that to work!<g> I don't think we will see a stock market crash if the FDA denies NPTH's PMA. The FDA denies companies all the time. Usually their competitors' share prices go up. Cisco